06/29/2026
Decentralized spirometry isn't a reimbursement strategy.
It's how 38 million Americans living with chronic lung disease finally get a confirmed diagnosis, the right treatment, and a care pathway that actually follows them.
84–87% of patients coded for chronic lung disease have never had a confirmatory spirometry test.
Not undiagnosed patients. Not people who haven't seen a physician. Patients already in your system. Already coded. Already on a care pathway — and the one test that confirms whether that diagnosis is accurate has never been performed.
This isn't a failure of care. It's the ceiling of what was previously possible.
Spirometry has always required a respiratory therapist, a pulmonary function lab, a referral, and a 6–8 week wait. 40% of patients never complete it. The ones who do wait months for a result that should have informed the first treatment decision.
The standard of care has been constrained by access — not by clinical intent.
That is changing.
When confirmatory diagnosis is available at every encounter — in primary care, urgent care, community health — everything downstream changes. The right diagnosis. The right therapy. The right medication. A care plan built on clinical truth, not clinical assumption.
Accurate coding, meaningful population health management, and reduced cost of care follow. Because the patient received the right diagnosis. Not the other way around.
MTI exists to make that standard achievable — at every clinic, at every encounter, for every patient.
What would it mean for your patient population if every coded respiratory patient had a confirmed diagnosis?
